Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RhinoPOC RCT
2024-512561-13-00Phase 4Authorised
- Sponsor
- University of Oulu
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in wheeze comparing Prednisolone with Placebo (sucrose) (2 arms). Primary endpoint: Time to fitness for discharge. Planned start Apr 2024; status: authorised.
02
Drugs
prednisolone
03
Conditions
wheeze
Beyond the preview
Go deeper on 2024-512561-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512561-13-00.